BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8042590)

  • 21. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-cell precursor bone marrow reconstitution after bone marrow transplantation.
    Leitenberg D; Rappeport JM; Smith BR
    Am J Clin Pathol; 1994 Aug; 102(2):231-6. PubMed ID: 8042594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
    Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
    Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD10 and CD19 fluorescence intensity of B-cell precursors in normal and leukemic bone marrow. Clinical characterization of CD10(+strong) and CD10(+weak) common acute lymphoblastic leukemia.
    Rego EM; Tone LG; Garcia AB; Falcão RP
    Leuk Res; 1999 May; 23(5):441-50. PubMed ID: 10374858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precursor B lymphoblastic lymphoma presenting as lytic bone lesions.
    Iravani S; Singleton TP; Ross CW; Schnitzer B
    Am J Clin Pathol; 1999 Dec; 112(6):836-43. PubMed ID: 10587707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.
    McKenna RW; Washington LT; Aquino DB; Picker LJ; Kroft SH
    Blood; 2001 Oct; 98(8):2498-507. PubMed ID: 11588048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicolor flow-cytometric, morphologic, and clonogenic analysis of marrow CD10-positive cells in children with leukemia in remission or nonmalignant diseases.
    Fukushima T; Sumazaki R; Koike K; Tsuchida M; Matsui A; Nakauchi H
    J Pediatr Hematol Oncol; 1998; 20(3):222-8. PubMed ID: 9628433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
    Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
    Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
    Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
    Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
    Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
    Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia.
    Rodríguez-Pardo VM; Aristizabal JA; Jaimes D; Quijano SM; de los Reyes I; Herrera MV; Solano J; Vernot JP
    Hematol Oncol Stem Cell Ther; 2013; 6(3-4):89-100. PubMed ID: 24161606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis.
    Sevilla DW; Emmons FN; Colovai AI; Beaubier NT; Baker C; Bhatia M; Bhagat G; Alobeid B
    Leuk Lymphoma; 2009 Dec; 50(12):1951-7. PubMed ID: 19860606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
    Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
    Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.
    Tembhare PR; Ghogale S; Ghatwai N; Badrinath Y; Kunder N; Patkar NV; Bibi AR; Chatterjee G; Arora B; Narula G; Banawali S; Deshpande N; Amare P; Gujral S; Subramanian PG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):100-111. PubMed ID: 27718302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematogones: The Supreme Mimicker and a Cytomorphological Confounder in Acute Lymphoblastic Leukemia.
    Singh K; Tiwari D; Boddu R; Somasundarum V; Mishra K
    J Lab Physicians; 2023 Jun; 15(2):212-216. PubMed ID: 37323612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.